EBI-2511 is primarily utilized in the field of pharmaceutical research and development, particularly in the study of targeted therapies for various diseases. Its application is significant in the investigation of enzyme inhibition, where it is used to explore potential treatments for conditions influenced by specific enzymatic pathways. Researchers employ EBI-2511 to understand its interaction with biological targets, aiming to develop novel drugs that can modulate these pathways effectively. Additionally, it plays a role in preclinical studies, helping to assess the efficacy and safety of new therapeutic candidates. The compound is also valuable in the synthesis of analogs and derivatives, which are tested for improved pharmacological properties. Overall, EBI-2511 contributes to advancing medical science by providing insights into the mechanisms of disease and aiding in the discovery of innovative treatments.